NuVasive shares dropped 13 percent after the company announced receiving a subpoena related to potentially false or improper Medicare and Medicaid claims, erasing more than $100 million in share value, according to a UT San Diego report.
Intrinsic Therapeutics has enrolled the 400th patient in a level 1, prospective, randomized, multi-center clinical trial to evaluate the Barricaid Prosthesis for lumbar discectomy patients.
Here are seven things for spine surgeons to know for Thursday, Aug. 1, 2013.
The article is written by Adam C. Powell, PhD, President of Payer+Provider Syndicate, a consulting firm which uses teams of economists, health services researchers and physicians to provide precise answers to operational challenges faced by health insurance companies and hospitals.
Good surgeon documentation can help make a practice run smoothly and stay profitable while poor documentation could have a huge negative impact on practices in the future. Here are five ways spine surgeon documentation can impact a practice, for better or for worse.
From 2003 to 2009, recombinant human bone morphogenic protein use in pediatric spinal fusion increased from use in 2.7 percent of cases to 9.3 percent of cases, with an average increase of 16 percent per year, according to a new study published in the Journal of Bone and Joint Surgery.
As spine care becomes more collaborative, surgeons are looking to strengthen their relationships with non-operative specialists or bring them into their professional practices.
Pain medication can help back pain patients on the road to recovery, but spine surgeons and specialists across the country are now faced with several challenges to ensure patients adhere to their regimen without abusing their prescription or diverting the pills somewhere else.
Preoperative cigarette smoking is not a predictor of poor perioperative outcomes for spinal surgery, according to a study in the July 1 issue of Spine.
The Food and Drug Administration granted 11 spine-related device clearances in June.